Biotech | May 12, 2022
Mawi DNA Technologies launches NextSWAB for Covid-19 test results
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
Formula attenuates 99% of 365 coronaviruses in computer models
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
ABDM is a critical integration that leverages an open, interoperable, standards-based digital system that is secure, and maintains confidentiality and privacy of health-related personal information
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Subscribe To Our Newsletter & Stay Updated
